跳至主要内容
临床试验/NL-OMON50762
NL-OMON50762已完成不适用

Evaluation of the safety and efficacy of the MHP- total hip arthroplasty - The MHP- total hip

Zimmer Biomet0 个研究点目标入组 21 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Zimmer Biomet
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • •1. Candidates for a total hip replacement because of arthritis of the hip.
  • •2. Patients with a good general condition.
  • •3. Patients willing and able to participate in the clinical trial with a 10
  • •years follow up and who have signed an informed consent.
  • •4. Males and females.
  • •5. Age between 55 and 75.
  • •6. Absence or little presence of osteoporotic bone (t>-2).
  • •7. ASA score 1 and 2.

排除标准

  • •Severe comorbidities

研究者

发起方
Zimmer Biomet

相似试验